TOCCA EXPANDS ITS REACH FOR FDA CLEARANCE BY DEVELOPING THE FIRST EVER TOCCA SCREEN DRUG TEST TOOL KIT...

TOCCA EXPANDS ITS REACH FOR FDA CLEARANCE BY DEVELOPING THE FIRST EVER TOCCA SCREEN DRUG TEST TOOL KIT THAT OFFERS PARENTS FREE MEMBERSHIP TO INSTRUCTIONAL ADVICE, VIDEO DEMONSTRATIONS AND MOST IMPORTANTLY, A NON-INVASIVE, NON- CONTROVERSIAL ABILITY TO START THE PROCESS FOR HOME AND WORKPLACE DRUG ACCOUNTABILITY.

May 24, 2016, LAKE WORTH FLORIDA. TOCCA Life Holdings, Inc. (OTC Pink: TLIF) announced today that they are ready to change up the industry of addiction by helping the family first and before the rampant selling bestowed upon the potential client. Instead of engaging in the current industry to sell the client for the immense profit margins that have hurt client care, TOCCA has remained nearly anonymous working on solutions during a quiet stay of watching the industry. The company has now created what may be considered the most organized client care pipeline of future business, simply by helping families first.

TOCCA is expanding the reach for FDA clearance, for the first ever TOCCA SCREEN Drug Test Tool Kit after years of experience, thousands of stories from clients and continued sales of individual products via TOCCALife.com and https://drugtestkits.toccalife.com. The kit is being set for mass market retail to change the way business is done. It focuses on family accountability first and before acceptance of client care. It is a “wake up call” to the industry and families. Business success expects to be eminent, however family support is the key element before, during and after, any type of client care.

TOCCA Life Holdings, Inc. CEO, Tyler Cornell explains, “$50 Million in cash payments at a cost of $49.95 exemplifies a willingness to learn by the family of the client. That should start us with a pipeline of nearly 1 Million potential clients for our core business. It creates an interactive relationship with the professionals of TOCCA long before the first intervention and a pipeline of steady revenue streams to invest into client care. It is one of the few ever product sales that have an “up-sell” of client care at exponentially higher revenues than that of the product sale. It is an active attempt to help families and potential clients from the disease of addiction. With client care and shareholders as the utmost priority, it is expected that TOCCA has developed the first attempt, within the 80 year old plus industry, to help people practice prevention while securing shareholders interests by formalizing its efforts in the homes of others. The effort is a way for people to become active in the lives of others by using the TOCCA SCREEN Drug Test Tool Kit. A way to help instead of being sold; A way to educate before, during and after intervention. It is a better slogan than, “Just Say No” but instead, a process to help eliminate the demand for drugs and the $650 Billion war against it. It helps take the mystery out of the disease.”

TOCCA contends the reach of their new TOCCA SCREEN drug test tool kit will excite the FDA, insurance companies and the public. It encompasses the needs of the public to start accountability within their own homes and balance the scales on multiple levels of the drug and drug rehabilitation industry with one swift movement. Included in the kit, along with available video demonstrations and instructional information, TOCCA SCREEN Drug Testing Tool Kit will include a non-invasive surface drug test. The test will allow parents and employers to test for the presence of pills and drugs on everything from a wallet to a desk or a cell phone to a company vehicle before the parents or employers confront the potential victim suffering from The Other Cancer Called Addiction.

Cornell continued, “TOCCA is a way of life everyone should appreciate. Society needs to help from the day before The Other Cancer Called Addiction is triggered upon its victim to the 7 months after they need clothes for their interview. Accountability within the home and work place using our professional methodology with our professional products is a great staging point to minimize the demand for drugs which cost taxpayers Hundreds of Billions of Dollars per year. We are setting the stage and we invite everyone to help us, help you.”

Safe Harbor Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company’s reports filed with OTC Markets.com. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.

Contact Information

Investor Relations
TOCCA Life Holdings, Inc.
[email protected]